Clinical Trial Update: Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. [Phase 2, Phase 3]

View source ↗

Summary

A multi-center randomized Phase 2/3 trial evaluating neoadjuvant hepatic arterial infusion chemotherapy with transarterial chemoembolization (TACE) plus donafen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Peking University | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: TERMINATED